Armata Pharmaceuticals (ARMP) Balance Sheet: Assets & Liabilities

Armata Pharmaceuticals (ARMP) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Armata Pharmaceuticals reported total assets of $76.88M and total liabilities of $295.48M. Shareholders' equity was negative at −$218.60M, meaning liabilities exceed assets. Total debt stood at $261.49M against $8.69M in cash and short-term investments, a net debt position of $252.80M.

Armata Pharmaceuticals Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Armata Pharmaceuticals, Inc. (ARMP) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Current Assets
Cash and Cash Equivalents	8.69	9.29	13.52	14.85	10.29	9.65	6.03	8.16	5.13
Cash & Short-Term Investments	8.69	9.29	13.52	14.85	10.29	9.65	6.03	8.16	5.13
Accounts Receivable	0.47	0.74	3.36	8.53	2.99	0.56	0.00	0.00	0.00
Inventory	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Assets	1.51	1.27	2.27	3.66	1.72	0.64	0.62	0.25	0.51
Total Current Assets	10.67	11.31	19.15	27.05	15.00	10.85	6.66	8.41	5.39
Non-Current Assets
Property, Plant & Equipment (Net)	46.11	54.93	57.28	46.65	38.07	12.84	4.22	0.50	0.82
Long-Term Investments	5.39	5.48	0.00	5.96	0.00	1.20	0.70	0.80	0.00
Goodwill	3.49	3.49	3.49	3.49	3.49	3.49	3.49	0.00	0.00
Intangible Assets	10.26	10.26	10.26	10.26	10.26	10.26	10.26	2.98	4.94
Other Non-Current Assets	6.36	6.46	8.19	8.39	2.96	-2.13	0.14	0.14	0.00
Total Non-Current Assets	66.21	75.13	79.21	68.79	54.77	28.67	18.80	3.48	5.75
Total Assets	76.88	86.44	98.36	95.83	69.77	39.52	25.45	11.89	11.14
Current Liabilities
Accounts Payable	0.92	0.77	1.59	1.68	1.14	0.96	0.55	0.73	0.58
Short-Term Debt	4.56	38.95	9.48	17.01	1.51	2.27	1.31	0.00	0.00
Current Portion of Long-Term Debt	-	38.95	-	-	-	-	-	-	-
Accrued Liabilities	0.78	1.29	0.77	4.36	1.13	1.54	-	-	-
Other Current Liabilities	0.49	0.53	5.40	6.18	2.17	3.48	3.02	1.84	1.39
Total Current Liabilities	8.95	48.25	16.46	24.87	4.81	6.71	4.88	2.57	1.97
Non-Current Liabilities
Long-Term Debt	256.92	55.44	110.89	31.80	36.48	10.88	1.56	0.00	0.00
Deferred Tax Liabilities	3.08	3.08	3.08	3.08	3.08	3.08	3.08	0.82	1.15
Other Non-Current Liabilities	0.00	3.08	0.00	3.08	3.08	0.00	1.35	0.02	0.29
Total Non-Current Liabilities	286.53	86.21	113.97	34.88	39.56	13.95	5.98	0.84	1.44
Total Liabilities	295.48	134.46	130.43	59.75	44.37	20.66	10.86	3.41	3.41
Stockholders' Equity
Common Stock	0.36	0.36	0.36	0.36	0.27	0.19	0.10	0.32	0.10
Retained Earnings	-501.53	-327.74	-308.82	-239.77	-202.86	-179.70	-157.52	-406.32	-394.21
Accumulated Other Comprehensive Income	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-11.14
Additional Paid-in Capital	282.57	279.35	276.39	275.49	227.98	198.37	172.02	414.47	0.00
Shares Outstanding	36.43	36.18	36.12	36.14	27.11	-	-	-	-
Total Stockholders' Equity	-218.60	-48.02	-32.07	36.08	25.40	18.86	14.59	8.47	7.73
Total Liabilities & Equity	76.88	86.44	98.36	95.83	69.77	39.52	25.45	11.89	11.14

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Armata Pharmaceuticals Balance Sheet

How much debt does Armata Pharmaceuticals have?

Armata Pharmaceuticals had total debt of $261.49M as of Dec 31, 2025, against $8.69M in cash and short-term investments. Total debt was $94.39M a year earlier.

What are Armata Pharmaceuticals's total assets?

Armata Pharmaceuticals reported total assets of $76.88M as of Dec 31, 2025, down 11.1% from $86.44M a year earlier. Total liabilities were $295.48M.

What is Armata Pharmaceuticals's shareholders' equity?

Armata Pharmaceuticals's shareholders' equity was negative at −$218.60M as of Dec 31, 2025, so its liabilities exceeded its assets.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition